Boston Children's Hospital
Boston, Massachusetts, 02115, United States
Location contact
Adam Porter, MPH
CONTACT
Laura Lehman, MD, MPH
SUB_INVESTIGATOR
Rebekah Mannix, MD, MPH
SUB_INVESTIGATOR
NCT Number: NCT07474675
The goal of this study is to test the efficacy of a rapid bedside blood test in determining if a stroke is happening in children who present to the emergency department with stroke symptoms. The main questions it aims to answer are:
* To determine the sensitivity of detecting a large vessel occlusion (LVO) as the etiology of acute ischemic stroke (AIS) in a pediatric population using a point-of-care blood-based assay (LVOne). * To determine the positive predictive value (PPV) of LVOne in a pediatric population
Participants will:
* Provide a small sample of blood to be used to test the accuracy of the device. * Participants will still receive all standard of care work-up for stroke, which could include computed tomography/magnetic resonance imaging (CT/MRI).
Trial opening soon.
Get Notified0 year–21 year
All sexes
Observational
Boston, Massachusetts, 02115, United States
Adam Porter, MPH
CONTACT
Laura Lehman, MD, MPH
SUB_INVESTIGATOR
Rebekah Mannix, MD, MPH
SUB_INVESTIGATOR
Neurologic emergencies, such as stroke, make up almost one-third of the most serious cases seen in pediatric emergency departments. Although stroke is less common in children than in adults, it is being diagnosed more often-especially in children under five years old-and it leads to much higher healthcare costs after the event. Despite how serious pediatric stroke can be, there is still no clear agreement on the best way to diagnose it quickly and safely.
One of the biggest challenges is that diagnosing stroke in children usually depends on advanced imaging tests like CT scans and MRI. CT scans expose children to radiation, which carries long-term risks, while MRI scans often require sedation and can be delayed due to limited availability. Even so, these tests are still needed to decide whether a child qualifies for treatments that can limit brain damage, such as clot-removal procedures. Any delay in diagnosis can significantly worsen outcomes. These problems are especially difficult in smaller or rural emergency departments, where children may need to be transferred to a specialized pediatric hospital-adding time, cost, and stress for families.
Because of these challenges, there is growing interest in simpler tests that could help doctors evaluate children more quickly. In particular, certain blood markers, such as GFAP and D-dimer, have been studied as possible indicators of stroke. While some blood tests for these markers have been approved for use in adults, they are often expensive and not widely available, and their usefulness in children is not well established. A newer option-called a lateral flow test, similar to a rapid pregnancy test-could offer a fast, low-cost, bedside alternative. Early studies in adults are encouraging. However, stroke is much less common in children: while most adults who arrive at the emergency department with sudden neurologic symptoms are having a stroke, only about 7% of children with similar symptoms actually are.
Although adult studies suggest that a rapid test using just a drop of blood from a finger prick may be able to detect certain types of stroke or rule out brain bleeding, this approach has not yet been properly studied in children. In this study, we aim to test whether a commercially available rapid bedside blood test can accurately help diagnose stroke in children who come to the emergency department with concerning symptoms.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this study, participants will provide a small sample of blood to test the accuracy and efficacy of the Rapid Assay device. Standard of care for diagnosis will follow, regardless of Assay outcomes.
Other names: LVOne
Time frame: From enrollment in study in the emergency department through completion of the diagnostic evaluation for stroke during the index ED visit (approximately up to 24 hours).
To determine the sensitivity of detecting an large vessel occlusion as the etiology of acute ischemic stroke.
Time frame: From enrollment in study in the emergency department through completion of the diagnostic evaluation for stroke during the index ED visit (approximately up to 24 hours).
To determine the Positive Predictive Value of LVOne for any imaging-confirmed acute ischemic stroke
Time frame: From enrollment in study in the emergency department through completion of the diagnostic evaluation for stroke during the index ED visit (approximately up to 24 hours).
To determine the Positive Predictive Value of LVOne for acute ischemic stroke with large vessel occlusion
Time frame: From enrollment in study in the emergency department through completion of the diagnostic evaluation for stroke during the index ED visit (approximately up to 24 hours).
To determine the specificity of LVOne for any imaging-confirmed acute ischemic stroke
Time frame: From enrollment in study in the emergency department through completion of the diagnostic evaluation for stroke during the index ED visit (approximately up to 24 hours).
To identify the frequency of indeterminate readout on LVOne assay
Contact information is provided by the study sponsor or research team.
Adam Porter, MPH
CONTACT
Thomas Stivers, MS
CONTACT
Boston Children's Hospital
Other
Evaluation of a Point-of-care Lateral Flow Assay in GFAP and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06332989
Brain Diseases, Cardiovascular Diseases
Leiden, Netherlands
View Trial DetailsNCT07526649
Acute Ischemic Stroke, Brain Diseases
Grafton, Auckland, New Zealand
View Trial DetailsNCT05899036
Acute Ischemic Stroke, Brain Diseases
Asunción, Paraguay
View Trial DetailsNCT07670065
Acute Ischemic Stroke, Brain Diseases
Beijing, China
View Trial Details